These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3106859

  • 1. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL, Jones K, Hansen S, Wall RA.
    Neurosci Lett; 1987 Mar 20; 75(1):65-70. PubMed ID: 3106859
    [Abstract] [Full Text] [Related]

  • 2. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Wall RA, Jones K.
    Neurosci Lett; 1986 Sep 12; 69(3):285-9. PubMed ID: 3489912
    [Abstract] [Full Text] [Related]

  • 3. Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
    Perry TL, Jones K, Hansen S.
    Neurosci Lett; 1988 Feb 15; 85(1):101-4. PubMed ID: 3362404
    [Abstract] [Full Text] [Related]

  • 4. Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM.
    J Neurol Sci; 1987 Nov 15; 81(2-3):321-31. PubMed ID: 3121800
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 15; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 6. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.
    Perry TL, Yong VW, Clavier RM, Jones K, Wright JM, Foulks JG, Wall RA.
    Neurosci Lett; 1985 Sep 30; 60(2):109-14. PubMed ID: 3877260
    [Abstract] [Full Text] [Related]

  • 7. Studies on semirigid tricyclic analogues of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Booth RG, Trevor A, Singer TP, Castagnoli N.
    J Med Chem; 1989 Feb 30; 32(2):473-7. PubMed ID: 2783613
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK, Sonsalla PK, Heikkila RE.
    J Neurochem; 1987 Mar 30; 48(3):929-34. PubMed ID: 3492590
    [Abstract] [Full Text] [Related]

  • 9. 2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease.
    Perry TL, Jones K, Hansen S, Wall RA.
    J Neurol Sci; 1988 Jul 30; 85(3):309-17. PubMed ID: 3210027
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Heikkila RE, Sieber BA, Manzino L, Sonsalla PK.
    Mol Chem Neuropathol; 1989 Jun 30; 10(3):171-83. PubMed ID: 2669769
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG, Xu DL, Yu HZ, Xu XR, Tang QM.
    Life Sci; 1987 May 18; 40(20):2007-10. PubMed ID: 2437428
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO.
    Eur J Neurosci; 2008 Jul 18; 28(1):41-50. PubMed ID: 18662333
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A.
    Neurosci Lett; 1986 Aug 29; 69(2):192-7. PubMed ID: 3489911
    [Abstract] [Full Text] [Related]

  • 20. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.
    Yong VW, Perry TL, Krisman AA.
    Neurosci Lett; 1986 Jan 02; 63(1):56-60. PubMed ID: 3485266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.